DeCode’s Genetic Breakthrough Barely Registers

DeCode’s Genetic Breakthrough Barely Registers DeCode Genetics published an important genetic map–assembled by methods very different from those used to create the sequence of the human genome–that will make it much easier for scientists to hunt down new genes linked to disease. But DeCode’s stock continues to languish.


Celera abandons gene sequencing

Celera abandons gene sequencing The company that shared the glory for unravelling the code of life of human beings has turned its back on gene sequencing. Celera Genomics of Rockville, Maryland, announced this week that it is to develop drugs instead


Get email updates

Get new actionable insights and updates from BiotechBlog

Biotechblog